Report Detail
Global (United States, European Union and China) Neurodegenerative Drugs Market Research Report 2019-2025
- RnM3650453 |
- 06 August, 2019 |
- Global |
- 114 Pages |
- QYResearch |
- Pharma & Healthcare
Neurodegenerative disease or neurodegeneration refers to the progressive damage or wear and tear of the nerve cells. Neurodegenerative disease causes loss of abilities like decision making and eventually memory loss. Neurodegeneration is a broader term which comprises of different disease namely Parkinson’s disease, Huntington disease, Amyotrophic Lateral Sclerosis and Alzheimer’s disease. These are the most commonly occurring diseases under the condition “Neurodegeneration”.
In 2019, the market size of Neurodegenerative Drugs is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Neurodegenerative Drugs.
This report studies the global market size of Neurodegenerative Drugs, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Neurodegenerative Drugs sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Novartis
Pfizer
Merck Serono
Biogen Idec
TEVA Pharmaceuticals
UCB
Boehringer Ingelheim
Sanofi
GlaxoSmithKline
Market Segment by Product Type
NMDA
SSRIs
Dopamine Inhibitors
Market Segment by Application
Hospital
Research
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Neurodegenerative Drugs status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Neurodegenerative Drugs manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Neurodegenerative Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Neurodegenerative Drugs Market Size Growth Rate by Type (2019-2025)
- 1.3.2 NMDA
- 1.3.3 SSRIs
- 1.3.4 Dopamine Inhibitors
- 1.4 Market Segment by Application
- 1.4.1 Global Neurodegenerative Drugs Market Share by Application (2019-2025)
- 1.4.2 Hospital
- 1.4.3 Research
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Neurodegenerative Drugs Market Size
- 2.1.1 Global Neurodegenerative Drugs Revenue 2014-2025
- 2.1.2 Global Neurodegenerative Drugs Sales 2014-2025
- 2.2 Neurodegenerative Drugs Growth Rate by Regions
- 2.2.1 Global Neurodegenerative Drugs Sales by Regions 2014-2019
- 2.2.2 Global Neurodegenerative Drugs Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Neurodegenerative Drugs Sales by Manufacturers
- 3.1.1 Neurodegenerative Drugs Sales by Manufacturers 2014-2019
- 3.1.2 Neurodegenerative Drugs Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Neurodegenerative Drugs Revenue by Manufacturers (2014-2019)
- 3.2.2 Neurodegenerative Drugs Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Neurodegenerative Drugs Market Concentration Ratio (CR5 and HHI)
- 3.3 Neurodegenerative Drugs Price by Manufacturers
- 3.4 Key Manufacturers Neurodegenerative Drugs Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Neurodegenerative Drugs Market
- 3.6 Key Manufacturers Neurodegenerative Drugs Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 NMDA Sales and Revenue (2014-2019)
- 4.1.2 SSRIs Sales and Revenue (2014-2019)
- 4.1.3 Dopamine Inhibitors Sales and Revenue (2014-2019)
- 4.2 Global Neurodegenerative Drugs Sales Market Share by Type
- 4.3 Global Neurodegenerative Drugs Revenue Market Share by Type
- 4.4 Neurodegenerative Drugs Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Neurodegenerative Drugs Sales by Application
6 United States
- 6.1 United States Neurodegenerative Drugs Breakdown Data by Company
- 6.2 United States Neurodegenerative Drugs Breakdown Data by Type
- 6.3 United States Neurodegenerative Drugs Breakdown Data by Application
7 European Union
- 7.1 European Union Neurodegenerative Drugs Breakdown Data by Company
- 7.2 European Union Neurodegenerative Drugs Breakdown Data by Type
- 7.3 European Union Neurodegenerative Drugs Breakdown Data by Application
8 China
- 8.1 China Neurodegenerative Drugs Breakdown Data by Company
- 8.2 China Neurodegenerative Drugs Breakdown Data by Type
- 8.3 China Neurodegenerative Drugs Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Neurodegenerative Drugs Breakdown Data by Company
- 9.2 Rest of World Neurodegenerative Drugs Breakdown Data by Type
- 9.3 Rest of World Neurodegenerative Drugs Breakdown Data by Application
- 9.4 Rest of World Neurodegenerative Drugs Breakdown Data by Countries
- 9.4.1 Rest of World Neurodegenerative Drugs Sales by Countries
- 9.4.2 Rest of World Neurodegenerative Drugs Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Novartis
- 10.1.1 Novartis Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Neurodegenerative Drugs
- 10.1.4 Neurodegenerative Drugs Product Introduction
- 10.1.5 Novartis Recent Development
- 10.2 Pfizer
- 10.2.1 Pfizer Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Neurodegenerative Drugs
- 10.2.4 Neurodegenerative Drugs Product Introduction
- 10.2.5 Pfizer Recent Development
- 10.3 Merck Serono
- 10.3.1 Merck Serono Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Neurodegenerative Drugs
- 10.3.4 Neurodegenerative Drugs Product Introduction
- 10.3.5 Merck Serono Recent Development
- 10.4 Biogen Idec
- 10.4.1 Biogen Idec Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Neurodegenerative Drugs
- 10.4.4 Neurodegenerative Drugs Product Introduction
- 10.4.5 Biogen Idec Recent Development
- 10.5 TEVA Pharmaceuticals
- 10.5.1 TEVA Pharmaceuticals Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Neurodegenerative Drugs
- 10.5.4 Neurodegenerative Drugs Product Introduction
- 10.5.5 TEVA Pharmaceuticals Recent Development
- 10.6 UCB
- 10.6.1 UCB Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Neurodegenerative Drugs
- 10.6.4 Neurodegenerative Drugs Product Introduction
- 10.6.5 UCB Recent Development
- 10.7 Boehringer Ingelheim
- 10.7.1 Boehringer Ingelheim Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Neurodegenerative Drugs
- 10.7.4 Neurodegenerative Drugs Product Introduction
- 10.7.5 Boehringer Ingelheim Recent Development
- 10.8 Sanofi
- 10.8.1 Sanofi Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Neurodegenerative Drugs
- 10.8.4 Neurodegenerative Drugs Product Introduction
- 10.8.5 Sanofi Recent Development
- 10.9 GlaxoSmithKline
- 10.9.1 GlaxoSmithKline Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Neurodegenerative Drugs
- 10.9.4 Neurodegenerative Drugs Product Introduction
- 10.9.5 GlaxoSmithKline Recent Development
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Neurodegenerative Drugs Sales Channels
- 11.2.2 Neurodegenerative Drugs Distributors
- 11.3 Neurodegenerative Drugs Customers
12 Market Forecast
- 12.1 Global Neurodegenerative Drugs Sales and Revenue Forecast 2019-2025
- 12.2 Global Neurodegenerative Drugs Sales Forecast by Type
- 12.3 Global Neurodegenerative Drugs Sales Forecast by Application
- 12.4 Neurodegenerative Drugs Forecast by Regions
- 12.4.1 Global Neurodegenerative Drugs Sales Forecast by Regions 2019-2025
- 12.4.2 Global Neurodegenerative Drugs Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Neurodegenerative Drugs. Industry analysis & Market Report on Neurodegenerative Drugs is a syndicated market report, published as Global (United States, European Union and China) Neurodegenerative Drugs Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Neurodegenerative Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
